Synthetic Genomics' Exxon Biofuel Pact Worth Up to $300M | GenomeWeb

NEW YORK (GenomeWeb News) –Synthetic Genomics has struck a biofuel research and development agreement with ExxonMobil Research and Engineering Company that could bring in up to $300 million for the genomics firm, the companies said today.

The agreement to develop biofuel from photosynthetic algae that would be compatible with gasoline and diesel fuels could bring in $300 million to SGI if certain milestones are met. Exxon plans to spend up to another $300 million internally to support the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.